S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

SBFMW Sunshine Biopharma Inc

0.2877

-0.0623 (-17.80%)

After Hours

Last Updated: 06:06:39

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Sunshine Biopharma (NASDAQ:SBFMW)
Historical Stock Chart
From Mar 2025 to Apr 2025

Click Here for more Sunshine Biopharma Charts.

Sunshine Biopharma (NASDAQ:SBFMW)
Historical Stock Chart
From Apr 2024 to Apr 2025

Click Here for more Sunshine Biopharma Charts.

Sunshine Biopharma Inc News

Form 8-K - Current report
Friday 4 April 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 4 April 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 3 April 2025 (3 weeks ago) • Edgar (US Regulatory)

This Pharma Stock Is Gaining Major Steam Ahead Of Opening Bell
Thursday 3 April 2025 (3 weeks ago) • AllPennyStocks.com

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 2 April 2025 (3 weeks ago) • Edgar (US Regulatory)

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Tuesday 1 April 2025 (3 weeks ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Saturday 15 February 2025 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 16 January 2025 (3 months ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Tuesday 7 January 2025 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 11 December 2024 (4 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (5 months ago) • Edgar (US Regulatory)

Form 424B4 - Prospectus [Rule 424(b)(4)]
Wednesday 13 November 2024 (5 months ago) • Edgar (US Regulatory)

More Sunshine Biopharma Inc News Articles

Sky City Entertainment

Whitefield Income

Tyrian Diagnostics

Amundi US Treasury Bond ...

SG ETC Daily Short-2X Na...

UBS LUX FUND SOLUTIONS -...

SG ETN Daily Short-1X Bt...

Exchange Traded

Laboratorio Farmaceutico...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions